Company / Income Tax
Ernexa Therapeutics Inc. Income Tax History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$30.0K
FY2025
5-year range
-$64.0K / $45.0K
FY2021-FY2025
Trend
+1100.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Income Tax changed +1100% YoY in FY2025, a notable deviation from the 9-year average annual change of +144%.
Based on SEC 10-K filings.
$30,000 in FY2025 with a 10-year CAGR of -9.8%.
Improved from $45,000 to $30,000 over the past 2 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +2.1%
- 10-Year CAGR
- -9.8%
Key checks
Key Insights
- 5-year CAGR of +2.1%, indicating consistent growth.
- In FY2025, income tax increased 1100.0% year-over-year.
- Peak income tax was recorded in FY2015.
- Lowest income tax in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $30.0K | +1100.0% |
| FY2024 | -$3.0K | -106.7% |
| FY2023 | $45.0K | +66.7% |
| FY2020 | $27.0K | +142.2% |
| FY2019 | -$64.0K | -197.0% |
| FY2018 | $66.0K | +73.7% |
| FY2017 | $38.0K | +216.7% |
| FY2016 | $12.0K | -85.7% |
| FY2015 | $84.0K | +82.6% |
| FY2014 | $46.0K | +155.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026